Viewing Study NCT05615792



Ignite Creation Date: 2024-05-06 @ 6:17 PM
Last Modification Date: 2024-10-26 @ 2:45 PM
Study NCT ID: NCT05615792
Status: COMPLETED
Last Update Posted: 2024-03-07
First Post: 2022-11-10

Brief Title: Observational Cohort of COVID-19 Patients in Hubei Province
Sponsor: Dao Wen Wang
Organization: Tongji Hospital

Study Overview

Official Title: Observational Cohort of The Effects of Clinical Indicators Drug Use and Genotypes on The Clinical Prognosis of COVID-19 Patients in Hubei Province
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OCCP-HP
Brief Summary: This study intends to use the relevant case data of COVID-19 in Hubei Province using big data processing and mining methods to evaluate the effects of clinical indicators drug use and genes on the clinical prognosis of COVID-19 patients so as to provide a theoretical basis for the treatment of these diseases and reduce the mortality
Detailed Description: Hubei Province as the forefront of the fight against epidemic has the largest number of patients infected with SARS-CoV-2 and the highest quality medical data However so far these data have not been fully analyzed if these data can not be mined and used it will be a great loss to the whole human race By fully mining and analyzing these data we can sum up a large number of experiences related to COVID-19 summarize various laws of this kind of disease and provide clinical evidence based on large samples for the research of this disease eventually contribute Chinas experience to the global fight against the epidemic

Based on the above background this study intends to use the relevant case data of COVID-19 in Hubei Province using big data processing and mining methods to evaluate the effects of clinical indicators drug use and genes on the clinical prognosis of COVID-19 patients so as to provide a theoretical basis for the treatment of these diseases and reduce the mortality

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None